Publication: Estimating drug shelf-life with unknown lot-to-lot variability
Issued Date
2015-01-01
Resource Type
ISSN
15324141
03610918
03610918
Other identifier(s)
2-s2.0-84929193366
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Communications in Statistics: Simulation and Computation. Vol.44, No.8 (2015), 2195-2207
Suggested Citation
N. Srimaneekarn, S. Kiatsupaibul, A. J. Hayter, W. Liu Estimating drug shelf-life with unknown lot-to-lot variability. Communications in Statistics: Simulation and Computation. Vol.44, No.8 (2015), 2195-2207. doi:10.1080/03610918.2013.854906 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/36208
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Estimating drug shelf-life with unknown lot-to-lot variability
Author(s)
Other Contributor(s)
Abstract
Copyright © 2015 Taylor & Francis Group, LLC. This article addresses the problem of estimating the shelf-life of a drug through a standard stability study that is routinely performed in the pharmaceutical industry. Based upon a dataset of the degradation of the drug efficacy over time, the objective is to estimate at what time point the drug efficacy falls below a minimally acceptable level. In this article, attention is directed toward the different roles played by lot-to-lot variability and measurement error in the performances of various estimation methodologies. The standard estimation method, as proposed by the United States Food and Drug Administration, for example, in accordance with current international guidelines, is compared with some new approaches. Simulation results are presented, which illustrate the advantages and disadvantages of the different estimation methodologies, and some recommendations and suggestions are made for shelf-life estimations.